687 related articles for article (PubMed ID: 18694602)
1. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approach.
Béland SG; Tournier M; Galbaud du Fort G; Crott R; Ducruet T; Pariente A; Moride Y
Value Health; 2011 Jun; 14(4):492-8. PubMed ID: 21669374
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
5. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
6. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
[TBL] [Abstract][Full Text] [Related]
9. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
11. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population.
McCombs JS; Nichol MB; Stimmel GL; Sclar DA; Beasley CM; Gross LS
J Clin Psychiatry; 1990 Jun; 51 Suppl():60-9; discussion 70-1. PubMed ID: 2189876
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.
Bhosle MJ; Reardon G; Camacho FT; Anderson RT; Balkrishnan R
Am J Geriatr Pharmacother; 2007 Jun; 5(2):100-11. PubMed ID: 17719512
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of antidepressant use in a cohort of pregnant women.
Ramos E; Oraichi D; Rey E; Blais L; Bérard A
BJOG; 2007 Sep; 114(9):1055-64. PubMed ID: 17565615
[TBL] [Abstract][Full Text] [Related]
14. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
[TBL] [Abstract][Full Text] [Related]
16. Potential clinical and economic impact of nonadherence with osteoporosis medications.
Hiligsmann M; Rabenda V; Gathon HJ; Ethgen O; Reginster JY
Calcif Tissue Int; 2010 Mar; 86(3):202-10. PubMed ID: 20205345
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of antidepressant treatment duration in naturalistic conditions.
Tournier M; Crott R; Gaudron Y; Verdoux H
Acta Psychiatr Scand; 2013 May; 127(5):365-72. PubMed ID: 23176590
[TBL] [Abstract][Full Text] [Related]
18. [The costs of depression and the cost-effectiveness of treatment].
König HH; Luppa M; Riedel-Heller S
Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
[No Abstract] [Full Text] [Related]
19. Patterns of antidepressant use in Quebec children and adolescents: trends and predictors.
Tournier M; Greenfield B; Galbaud du Fort G; Ducruet T; Zito JM; Cloutier AM; Moride Y
Psychiatry Res; 2010 Aug; 179(1):57-63. PubMed ID: 20621363
[TBL] [Abstract][Full Text] [Related]
20. Health care resource use associated with integrated psychological treatment.
Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
